INCRUSE ELLIPTA
GLAXOSMITHKLINE INC
Quick answers
Is there a shortage of INCRUSE ELLIPTA in Canada?
No. There is no current shortage of INCRUSE ELLIPTA 62.5MCG reported to Health Canada. Stock can still vary from one pharmacy to another.
Can I still get this?No shortage reported — confirm local stock with your pharmacy
StatusNo shortage on file
Same-ingredient products on fileNone found
DIN
02423596
Strength
62.5MCG
Dosage Form
Powder
Route
Inhalation
Active Ingredient
UMECLIDINIUM (UMECLIDINIUM BROMIDE)
See all UMECLIDINIUM (UMECLIDINIUM BROMIDE) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from GLAXOSMITHKLINE INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
ADVAIR
DIN 02245127
ADVAIR
DIN 02245126
ADVAIR 100 DISKUS
DIN 02240835
ADVAIR 250 DISKUS
DIN 02240836
ADVAIR 500 DISKUS
DIN 02240837
AMERGE
1MG · DIN 02237820
AMERGE
2.5MG · DIN 02237821
ANORO ELLIPTA
DIN 02418401
AREXVY
120MCG · DIN 02540207
ARNUITY ELLIPTA
100MCG · DIN 02446561
ARNUITY ELLIPTA
200MCG · DIN 02446588
AVAMYS
27.5MCG · DIN 02298589